Felix Fleisch
Characteristics of Three Different Chemiluminescence Assays for Testing for SARS-CoV-2 Antibodies
Weber M, Imperiali M, Salimi Y, Fleisch F, Cusini A, Heer S, Renz H, Paprotny M, Kohler P, Vernazza P, Risch L, Bodmer T, Egli K, Risch M, Thiel S, Grossmann K, Nigg S, Wohlwend N, Lung T, Hillmann D, Ritzler M, Ferrara F, Bigler S, Kahlert C. Characteristics of Three Different Chemiluminescence Assays for Testing for SARS-CoV-2 Antibodies. Dis Markers 2021; 2021:8810196.
06.01.2021Characteristics of Three Different Chemiluminescence Assays for Testing for SARS-CoV-2 Antibodies
06.01.2021Dis Markers 2021; 2021:8810196
Weber Myriam C, Imperiali Mauro, Salimi Yacir, Fleisch Felix, Cusini Alexia, Heer Sonja, Renz Harald, Paprotny Matthias, Kohler Philipp, Vernazza Pietro, Risch Lorenz, Bodmer Thomas, Egli Konrad, Risch Martin, Thiel Sarah L, Grossmann Kirsten, Nigg Susanne, Wohlwend Nadia, Lung Thomas, Hillmann Dorothea, Ritzler Michael, Ferrara Francesca, Bigler Susanna, Kahlert Christian
Temporal Course of SARS-CoV-2 Antibody Positivity in Patients with COVID-19 following the First Clinical Presentation
Risch M, Imperiali M, Salimi Y, Fleisch F, Cusini A, Renz H, Kohler P, Vernazza P, Kahlert C, Paprotny M, Bodmer T, Egli K, Weber M, Thiel S, Grossmann K, Wohlwend N, Lung T, Hillmann D, Ritzler M, Ferrara F, Bigler S, Risch L. Temporal Course of SARS-CoV-2 Antibody Positivity in Patients with COVID-19 following the First Clinical Presentation. Biomed Res Int 2020; 2020:9878453.
16.11.2020Temporal Course of SARS-CoV-2 Antibody Positivity in Patients with COVID-19 following the First Clinical Presentation
16.11.2020Biomed Res Int 2020; 2020:9878453
Risch Martin, Imperiali Mauro, Salimi Yacir, Fleisch Felix, Cusini Alexia, Renz Harald, Kohler Philipp, Vernazza Pietro, Kahlert Christian, Paprotny Matthias, Bodmer Thomas, Egli Konrad, Weber Myriam, Thiel Sarah, Grossmann Kirsten, Wohlwend Nadia, Lung Thomas, Hillmann Dorothea, Ritzler Michael, Ferrara Francesca, Bigler Susanna, Risch Lorenz
Flattening the curve in 52 days: characterisation of the COVID-19 pandemic in the Principality of Liechtenstein - an observational study
Thiel S, Copeland S, Karajan T, Cusini A, Fleisch F, Kahlert C, Vernazza P, Risch M, Ritzler M, Hillmann D, Lung T, Wohlwend N, Risch L, Weber M, Paprotny M. Flattening the curve in 52 days: characterisation of the COVID-19 pandemic in the Principality of Liechtenstein - an observational study. Swiss Med Wkly 2020; 150:w20361.
16.10.2020Flattening the curve in 52 days: characterisation of the COVID-19 pandemic in the Principality of Liechtenstein - an observational study
16.10.2020Swiss Med Wkly 2020; 150:w20361
Thiel Sarah Lucia, Copeland Sandra, Karajan Tomas V, Cusini Alexia, Fleisch Felix, Kahlert Christian, Vernazza Pietro, Risch Martin, Ritzler Michael, Hillmann Dorothea, Lung Thomas, Wohlwend Nadia, Risch Lorenz, Weber Myriam Carol, Paprotny Matthias
Fatal herpes simplex virus hepatitis in a patient with esophageal cancer under radiochemotherapy
Grimm B, Padberg B, Ruhstaller T, Fleisch F, von Moos R. Fatal herpes simplex virus hepatitis in a patient with esophageal cancer under radiochemotherapy. Onkologie 2008; 31:620-2.
01.11.2008Fatal herpes simplex virus hepatitis in a patient with esophageal cancer under radiochemotherapy
01.11.2008Onkologie 2008; 31:620-2
Grimm Birgit, Padberg Barbara, Ruhstaller Thomas, Fleisch Felix, von Moos Roger